Spero Therapeutics, Inc. (SPRO)

Last Three Months

30-Jan-24 -- 29-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

15

0

5

+1

0

+2

0

+3

Two Year Chart

30-Apr-22 -- 29-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Feb-24 8:48 PM View:	02-Feb-24 Sale ($42.34K)	Joseph Tamara L Chief Legal Officer		Spero Therapeutics, Inc. - SPRO	65% 322.79K to 531.62K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 8:45 PM View:	02-Feb-24 Sale ($38.46K)	Hamed Kamal Chief Medical Officer		Spero Therapeutics, Inc. - SPRO	37% 576.46K to 788.12K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 8:40 PM View:	05-Feb-24 Sale (Planned) ($65.38K)	Shukla Sath CEO and President Director		Spero Therapeutics, Inc. - SPRO	105% 572.5K to 1.18M	0	0	--	--	Show Txns Hide Txns

05-Feb-24 8:50 PM View:	02-Feb-24 Sale ($87.40K)	Mahadevia Ankit Director		Spero Therapeutics, Inc. - SPRO	(8%) 808.79K to 745.0K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 8:44 PM View:	01-Feb-24 Grant 0	Rajavelu Esther See Remarks		Spero Therapeutics, Inc. - SPRO	40% 300.0K to 419.87K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 8:53 PM View:	02-Feb-24 Sale ($42.12K)	Keutzer Timothy Chief Operating Officer		Spero Therapeutics, Inc. - SPRO	64% 325.29K to 534.05K	0	0	--	--	Show Txns Hide Txns